# Journal of immunotherapy

Source: https://onco.cc/journals/journal-of-immunotherapy/  
OnCo record `journal-of-immunotherapy` (Journal). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A long-established journal on using the immune system against cancer, edited by Steven Rosenberg of the US National Cancer Institute. Read by tumour immunologists and clinicians working on checkpoint inhibitors, vaccines and cell therapies.

## Summary

The Journal of Immunotherapy is published by Lippincott Williams & Wilkins, part of Wolters Kluwer, and its journal page on the Ovid platform gives Steven A. Rosenberg, MD, PhD as editor-in-chief, nine issues a year, and the ISSNs 1524-9557 (print) and 1537-4513 (online); the current issue at the time of writing is volume 49 (September 2026). NLM catalogues the title from 1997 as the continuation of the Journal of Immunotherapy with Emphasis on Tumor Immunology (ISSN 1067-5582), records it as the official journal of the Society for Biological Therapy, and indexes it for MEDLINE under Immunotherapy and Neoplasms. The journal is not listed in the Directory of Open Access Journals and its access model is not stated on the pages reached, so none is recorded here.

## Fields

- Kind: Journal
- Last checked: 2026-09-10
- Also known as: J Immunother; Journal of Immunotherapy with Emphasis on Tumor Immunology
- Publisher: Lippincott Williams & Wilkins (Wolters Kluwer)
- Scope: cancer immunotherapy

## Sources

- Homepage: https://www.ovid.com/jnls/immunotherapy-journal
- NLM Catalog: https://www.ncbi.nlm.nih.gov/nlmcatalog/9706083

## Connected records

- collections: [PubMed & Europe PMC](https://onco.cc/collections/pubmed-europepmc/)
- fronts: [Immunotherapy](https://onco.cc/fronts/immunotherapy/)
- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/)

---
JSON: https://onco.cc/api/v1/entities/journal-of-immunotherapy.json